Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management and subsequently approved for chronic weight management
This shift is reshaping market dynamics, with evolving regulatory oversight on Ozempic alternatives, emerging price competition across brands, and expanding investment opportunities in Indias pharmaceutical and biopharma manufacturing ecosystem
Alcohol poisoning can lead to coma or death due to slowed breathing, choking on vomit, or severe dehydration
Care has been taken to ensure accuracy, though readers are advised to verify key details from reliable sources
Dont get me wrong from an efficacy standpoint, these drugs work. Those who can afford, tolerate, and sustain GLP-1 use absolutely lose weight